{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"29.0","upperLimit":"141.0","value":"69.5"},{"groupId":"OG001","lowerLimit":"29.0","upperLimit":"115.0","value":"85.5"},{"groupId":"OG002","lowerLimit":"30.0","upperLimit":"113.0","value":"82.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"139"}],"units":"Participants"}],"description":"Time to response were summarized. A Kaplan-Meier analysis of time to progression was performed, including estimation and 95% confidence interval of the median time to progression and progression-free survival.","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants received Panobinostat 20 mg/day capsule orally, OD on 3 days per week. (Monday, Wednesday and Friday or alternative Day 1, 3 and 5). The treatment duration was not fixed. Participants continued treatment until disease progression or unacceptable toxicity occurred.","id":"OG000","title":"Bexarotene Exposed"},{"description":"Participants received Panobinostat 20 mg/day capsule orally, OD on 3 days per week. (Monday, Wednesday and Friday or alternative Day 1, 3 and 5). The treatment duration was not fixed. Participants continued treatment until disease progression or unacceptable toxicity occurred.","id":"OG001","title":"Bexarotene Naive"},{"description":"Participants received Panobinostat 20 mg/day capsule orally, OD on 3 days per week. (Monday, Wednesday and Friday or alternative Day 1, 3 and 5). The treatment duration was not fixed. Participants continued treatment until disease progression or unacceptable toxicity occurred.","id":"OG002","title":"All Participants"}],"paramType":"MEDIAN","populationDescription":"The analysis was performed in FAS population was defined according to the intention-to-treat principle. This population will include all participants enrolled into the study.","reportingStatus":"POSTED","timeFrame":"Baseline up to Cycle 12, an average of 12 months","title":"Time to Response for Responders","type":"SECONDARY","unitOfMeasure":"Days"}